Curated News
By: NewsRamp Editorial Staff
November 05, 2024
Zynex Inc. (NASDAQ: ZYXI) Steady Rise in the Pain Management Market
TLDR
- Zynex Inc. (NASDAQ: ZYXI) has carved out a unique space in the pain management market, with a mission to deliver innovative, drug-free solutions.
- The TensWave device, using TENS technology, offers a non-invasive pain relief option that complements Zynex's flagship device, the NexWave.
- Zynex's commitment to research and development aims to diversify its product portfolio to address unmet needs in pain management, delivering effective, drug-free pain solutions.
- Advancements in medical tech have opened doors to safer, non-invasive pain relief options, making them more widely adopted by healthcare providers.
Impact - Why it Matters
This news matters as it highlights the growing demand for non-invasive pain management solutions and the significant impact of Zynex Inc.'s innovative TensWave device in the market. It also showcases the company's resilience, expansion, and steady growth, providing lasting value for patients and shareholders alike.
Summary
Demand for pain management devices is climbing worldwide, fueled by several major trends. As chronic disease rates soar, the need for effective, drug-free pain solutions has grown more pressing. Advancements in medical tech have opened doors to safer, non-invasive pain relief options, and rising numbers of surgeries have created a strong demand for post-operative pain control. With these combined factors, the global pain management device market is expected to reach $5.68 billion by 2032, expanding at a steady 9% CAGR. Zynex Inc. stands out as a key player, bringing new solutions to the growing pain management market with its FDA-cleared TensWave device and strong financial performance through Q3 2024.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Zynex Inc. (NASDAQ: ZYXI) Steady Rise in the Pain Management Market